ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,784Medicare Part D Prescriptions Filled, Including Refills

Rank: 127 out of 917

$542K Total Retail Price of All Prescriptions

Rank: 94 out of 917

669 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 669 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 669 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 7,169 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
SIMVASTATIN 438 399 1 2
LISINOPRIL 399 351 2 1
LEVOTHYROXINE SODIUM 332 299 3 3
HYDROCODONE-ACETAMINOPHEN 313 144 S3 4 6
ATENOLOL 253 245 5 12
WARFARIN SODIUM 213 204 6 10
FUROSEMIDE 201 181 7 7
ZOLPIDEM TARTRATE 167 140 8 21
TRIAMTERENE-HCTZ 154 137 9 36
AMLODIPINE BESYLATE 153 137 10 5
PREDNISONE 149 137 11 34
ATORVASTATIN CALCIUM 138 122 12 14
HYDROCHLOROTHIAZIDE 127 122 13 9
METFORMIN HCL 111 111 14 8
AZITHROMYCIN 110 90 15 61
OMEPRAZOLE 109 89 16 4
CITALOPRAM HBR 105 100 17 15
DICLOFENAC SODIUM 105 80 17 117
METOPROLOL SUCCINATE 99 96 19 18
TRAZODONE HCL 96 50 20 22
OXYCODONE HCL 93 33 S2 21 27
FLUTICASONE PROPIONATE 92 73 22 26
LOVASTATIN 84 81 23 19
CARISOPRODOL 82 46 R 24 144
POTASSIUM CHLORIDE 82 76 24 16
CEPHALEXIN 80 63 26 105
TAMSULOSIN HCL 78 58 27 25
LOSARTAN POTASSIUM 77 73 28 13
LIOTHYRONINE SODIUM 72 68 29 306
ACETAMINOPHEN-CODEINE 72 45 S3 29 109
ACYCLOVIR 65 37 31 199
MIRTAZAPINE 60 33 32 39
METHADONE HCL 60 0 S2 32 59
DIGOXIN 59 59 34 41
ALLOPURINOL 58 46 35 31
CELEBREX 58 33 35 124
FLUOXETINE HCL 52 47 37 38
TRIAMCINOLONE ACETONIDE 52 36 37 96
SERTRALINE HCL 52 38 37 24
TRAMADOL HCL 52 46 37 28
BUPROPION HCL SR 51 28 41 101
PREMARIN 51 51 R 41 146
OXYCODONE-ACETAMINOPHEN 50 31 S2 43 46
SUMATRIPTAN SUCCINATE 50 12 43 288
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.